Competition for pharmaceutical government contracts rises


According to UOBKH, Duopharma’s management had said before that it would like to maintain earnings contribution from the government by winning a larger slice of the Health Ministry’s (MoH) contracts at lower margins

PETALING JAYA: Competition for government contracts among generic producers will be heightened even as the deadline for tenders by the end of the year draws near, says UOB Kay Hian Research (UOBKH).

“We gather that Pharmaniaga Bhd is ready to tender for 25 additional and new products. Tenders had historically ranged between RM40mil and RM60mil per tender, ” it said.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Sentral REIT appoints Tay Hui Ling as CEO
Mega First to acquire 12.5% stake in Stenta Films for RM33.10mil
DXN inks MoU with Apex-Brasil to explore Brazil, eyes US$50mil investments
F&N to focus on innovation, diversification and transformation
Mulpha International invests US$20mil in Hong Kong's Sun Hung Kai bond programme
Ringgit breaches 4.04 level against US dollar after OPR maintained at 2.75%
Capital A’s Teleport to raise US$50mil via perpetual securities
Apex Healthcare to be delisted on Jan 27
Prudential to raise stake in Malaysia life insurer holding firm to 70% for US$377mil
BWYS shareholders approve RM67mil property disposal, RM94.5mil land acquisition

Others Also Read